Health News

WASHINGTON (MedPage Today) — The FDA announced that it will require the labels of varenicline (Chantix) and bupropion (Zyban, Wellbutrin, and generics) to carry boxed warnings on the risk of serious neuropsychiatric symptoms starting today.

Read more

Filed under: General Health News
Tags: Drug, General Health News, mental

Related posts

• Substance Abuse Main Driver of Violence in Schizophrenia, Psychoses (0)
  A large systematic review shows that drug abuse, not mental illness itself, is the leading risk factor for violence in individuals with schizophrenia and other psychoses. Medscape Medical News Read more [tags] General Health News [/tags]
  
  
• New drug target in obesity: Fat cells make lots of melanin (0)
  (Federation of American Societies for Experimental Biology) As millions of Americans gear up for the Thanksgiving holiday, a new report published online in the FASEB Journal, may provide some relief for those leery second helpings. Researchers describe a discovery that may allow some obese people avoid common obesity-related metabolic problems without losing weight: they [...]
  
  
• Is it possible to eradicate homelessness? (0)
  (Economic & Social Research Council) A major new £692,000 ($959,000) research initiative launches today with the aim of informing government policy and practice and finding solutions to bring vulnerable homeless people in from the margins of our society. The initiative intends to develop a greater understanding of homeless people who have to cope with [...]
  
  
• Impact of narcotics is greater on mentally ill (0)
  (University of Montreal) Narcotics have an irreversible effect on the brains of people already suffering from mental illness, according to Dr. Stephane Potvin of the Universite de Montreal affiliated Centre de recherche Fernand-Seguin at the Louis-H Lafontaine Hospital. According to his research, some 33 to 50 percent of psychiatric patients also suffer from drug addiction Read [...]
  
  
• 3-substituted indolones as novel therapeutic compounds for neurodegenerative conditions (0)
  (Society for Experimental Biology and Medicine) Neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and ALS affect millions of individuals every year. Current medications are modestly effective, at best, and only target the symptoms associated with these debilitating and fatal disorders. Drugs to prevent or slow down the death of neurons are urgently [...]